These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 20415653)
1. MicroRNA regulation as a therapeutic strategy for cardiovascular disease. Montgomery RL; van Rooij E Curr Drug Targets; 2010 Aug; 11(8):936-42. PubMed ID: 20415653 [TBL] [Abstract][Full Text] [Related]
2. Toward microRNA-based therapeutics for heart disease: the sense in antisense. van Rooij E; Marshall WS; Olson EN Circ Res; 2008 Oct; 103(9):919-28. PubMed ID: 18948630 [TBL] [Abstract][Full Text] [Related]
3. Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis. Wang J; Liew OW; Richards AM; Chen YT Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213331 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA regulation in cardiovascular disease. da Costa Martins PA; Leptidis S; Salic K; De Windt LJ Curr Drug Targets; 2010 Aug; 11(8):900-6. PubMed ID: 20415652 [TBL] [Abstract][Full Text] [Related]
5. The emerging role of microRNAs as a therapeutic target for cardiovascular disease. Seok HY; Wang DZ BioDrugs; 2010 Jun; 24(3):147-55. PubMed ID: 20462281 [TBL] [Abstract][Full Text] [Related]
6. Development of microRNA therapeutics is coming of age. van Rooij E; Kauppinen S EMBO Mol Med; 2014 Jul; 6(7):851-64. PubMed ID: 24935956 [TBL] [Abstract][Full Text] [Related]
8. Potential roles of microRNA-1 and microRNA-133 in cardiovascular disease. Song Z; Gao R; Yan B Rev Cardiovasc Med; 2020 Mar; 21(1):57-64. PubMed ID: 32259904 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic advances in MicroRNA targeting. Montgomery RL; van Rooij E J Cardiovasc Pharmacol; 2011 Jan; 57(1):1-7. PubMed ID: 20729755 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA Mirn122a reduces expression of the posttranscriptionally regulated germ cell transition protein 2 (Tnp2) messenger RNA (mRNA) by mRNA cleavage. Yu Z; Raabe T; Hecht NB Biol Reprod; 2005 Sep; 73(3):427-33. PubMed ID: 15901636 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-based therapeutic approaches in the cardiovascular system. Fiedler J; Gupta SK; Thum T Cardiovasc Ther; 2012 Feb; 30(1):e9-e15. PubMed ID: 20946325 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker. Huang Y; Li J J Physiol Biochem; 2015 Sep; 71(3):479-86. PubMed ID: 25840809 [TBL] [Abstract][Full Text] [Related]
14. The role of microRNAs in heart failure. Wang H; Cai J Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):2019-2030. PubMed ID: 27916680 [TBL] [Abstract][Full Text] [Related]
15. MicroRNAs: role in cardiovascular biology and disease. Zhang C Clin Sci (Lond); 2008 Jun; 114(12):699-706. PubMed ID: 18474027 [TBL] [Abstract][Full Text] [Related]
16. Roles of microRNAs in pressure overload- and ischemia-related myocardial remodeling. Zhou S; Liu Y; Prater K; Zheng Y; Cai L Life Sci; 2013 Nov; 93(23):855-62. PubMed ID: 24021888 [TBL] [Abstract][Full Text] [Related]
17. Small non-coding RNA therapeutics for cardiovascular disease. Shah AM; Giacca M Eur Heart J; 2022 Nov; 43(43):4548-4561. PubMed ID: 36106499 [TBL] [Abstract][Full Text] [Related]